↓ Skip to main content

Naproxen with or without an antiemetic for acute migraine headaches in adults

Overview of attention for article published in Cochrane database of systematic reviews, October 2013
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

blogs
2 blogs
twitter
57 tweeters
reddit
1 Redditor

Citations

dimensions_citation
25 Dimensions

Readers on

mendeley
182 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Naproxen with or without an antiemetic for acute migraine headaches in adults
Published in
Cochrane database of systematic reviews, October 2013
DOI 10.1002/14651858.cd009455.pub2
Pubmed ID
Authors

Simon Law, Sheena Derry, R Andrew Moore

Abstract

Migraine is a common, disabling condition and a burden for the individual, health services, and society. Many sufferers choose not to, or are unable to, seek professional help and rely on over-the-counter analgesics. Naproxen is a non-steroidal anti-inflammatory drug (NSAID); its efficacy in acute migraine has not been established by systematic reviews. Co-therapy with an antiemetic should help to reduce the nausea and vomiting commonly associated with migraine headaches.

Twitter Demographics

The data shown below were collected from the profiles of 57 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 182 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 2 1%
Colombia 2 1%
Netherlands 1 <1%
Denmark 1 <1%
Ecuador 1 <1%
Unknown 175 96%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 39 21%
Unspecified 33 18%
Student > Master 24 13%
Student > Ph. D. Student 18 10%
Researcher 17 9%
Other 50 27%
Unknown 1 <1%
Readers by discipline Count As %
Medicine and Dentistry 72 40%
Unspecified 37 20%
Nursing and Health Professions 14 8%
Pharmacology, Toxicology and Pharmaceutical Science 11 6%
Psychology 10 5%
Other 37 20%
Unknown 1 <1%

Attention Score in Context

This research output has an Altmetric Attention Score of 48. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 September 2018.
All research outputs
#302,412
of 12,346,626 outputs
Outputs from Cochrane database of systematic reviews
#740
of 8,444 outputs
Outputs of similar age
#4,879
of 167,796 outputs
Outputs of similar age from Cochrane database of systematic reviews
#8
of 86 outputs
Altmetric has tracked 12,346,626 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,444 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 19.8. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 167,796 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 86 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.